ticker,published_utc,title,publisher,url
ARWR,2025-11-06T21:30:00+00:00,Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Year-End Results,Yahoo,https://finnhub.io/api/news?id=404b53951d7290f0acea0c4db518a761c20ca5b8b241585a7889df2d2811c71c
ARWR,2025-11-04T12:30:00+00:00,Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences,Yahoo,https://finnhub.io/api/news?id=aea71cfdeaab5e6edb6dc5f9b4e035b95bc37f776781c9eca8a59fd12b884b0c
ARWR,2025-10-28T20:30:00+00:00,Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),Yahoo,https://finnhub.io/api/news?id=24ad376ff39c4b1239a04bc04f7ce15e263c0f669fb79ff345d13cc7228440e3
ARWR,2025-10-23T23:18:06+00:00,How Arrowhead’s Evolving Story Is Shaping Analyst Views and Fair Value Targets,Yahoo,https://finnhub.io/api/news?id=6cf99483272eab663fee9b2792ccff387291085a07524dbe30259d3e05a8117c
ARWR,2025-10-22T17:00:00+00:00,"Complement 3 Glomerulopathy Market Poised for Phenomenal Expansion at a CAGR of 37.2% During the Forecast Period (2025–2034) Owing to the Launch of Promising Therapies Targeting C3, C5, MASP-3, and RNAi | DelveInsight",Yahoo,https://finnhub.io/api/news?id=b68806d91f6277806e557f80c5bcae2751dd346f8c43fe92330d2c84fb531d50
ARWR,2025-10-21T11:30:00+00:00,Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis,Yahoo,https://finnhub.io/api/news?id=8e93087e9bb262622a05ff2e84afbd5a7964480b9ba0170190a976413188809c
ARWR,2025-10-07T11:30:00+00:00,Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia,Yahoo,https://finnhub.io/api/news?id=66b4c1e23c93b377446ad74cb3b1330d4a93f1d7c7eef97cd14981dc1d9f8900
ARWR,2025-10-07T11:05:00+00:00,RNAi: The Benefits Of Shooting The Messenger,SeekingAlpha,https://finnhub.io/api/news?id=bbc39b1aacf9ec2d1e724bc671759a964ba5da1b0e83d6763ba72aca3dcbd1e2
ARWR,2025-10-03T18:14:40+00:00,Sarepta (SRPT) on Soars 15.7% on 5th Day Ahead of Clinical Trial Results,Yahoo,https://finnhub.io/api/news?id=d0c1ca4c1c77301b9048b0b6b13b2fc6c43633b8b00fae2397975bdfd072ca59
ARWR,2025-10-03T10:08:15+00:00,"Sarepta: Q3 Earnings An Upcoming Catalyst, But Risks Undermine Any Contrarian Play",SeekingAlpha,https://finnhub.io/api/news?id=13142b04cbb4a9346632e370ded3ff4c90750fff4822046ca99587c602211d0a
ARWR,2025-10-01T10:09:15+00:00,"Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Intrinsic Value Is Potentially 72% Above Its Share Price",Yahoo,https://finnhub.io/api/news?id=ec7475df71710500181e05b066d4934b6c2389d85e68e54d4b6cd581175f5f0a
ARWR,2025-09-24T17:40:34+00:00,"Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually",SeekingAlpha,https://finnhub.io/api/news?id=7ecb21fb8423fde87617c6680b90e9f8522d8dbd7307e733cd3cdfce246117e3
ARWR,2025-09-18T12:14:45+00:00,Roche Expands Cardiometabolic Pipeline With 89bio Acquisition,SeekingAlpha,https://finnhub.io/api/news?id=e5d6bc9c0433ae7840b92cc5f9abd527cac0e31858a011bdae1826eba04fb54e
ARWR,2025-09-11T12:30:00+00:00,Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals,Yahoo,https://finnhub.io/api/news?id=429a8025062cb2eec3740ed396dd9299fd2438f9356c2dc7727702a6bdcbd0d7
ARWR,2025-09-10T14:55:37+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=bae2b5cd1f45977fb6f07242434f971d0384cf3b28cc4be9056a671491d82ce6
ARWR,2025-09-10T12:30:00+00:00,Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies,Yahoo,https://finnhub.io/api/news?id=71e8fdf9a393fd98440838e7bf81b028d68a2618e945ca63333aac537489d2fd
ARWR,2025-09-10T05:59:37+00:00,H.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR),Yahoo,https://finnhub.io/api/news?id=f63c19a8383c7b5ed36c52524e80d8a7525977109694e41cfec04a4d126ed0a9
ARWR,2025-09-09T13:42:02+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=8d18ae31b306b13ad314eaec74b374150ce9d24281bd1dac3681bf0847813c55
ARWR,2025-09-07T21:35:51+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Presents At Cantor Global Healthcare Conference 2025 Transcript",SeekingAlpha,https://finnhub.io/api/news?id=88ac43bac7e6590fd3724c5832fc6b9fd7ed8ecd0e3c385fb65c6bb668b40f02
ARWR,2025-09-05T12:44:14+00:00,Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal,Yahoo,https://finnhub.io/api/news?id=1ddbd923712cb73fdbd741eca1cc4ed257588fb1bf8c82b0ac7f940cd88fbea8
ARWR,2025-09-03T21:14:28+00:00,Arrowhead Lands Billion-Dollar Biotech Deal: Stock Soars Double-Digits,Yahoo,https://finnhub.io/api/news?id=1ddfbde6fa6f75d7ac567862083b8f48e49f0b8d4e85e9aadbf95555442e7ed6
ARWR,2025-09-03T16:00:40+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Presents At Citi's 2025 Biopharma Back To School Conference (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=73e6808cf3e216eb37b80970216953a36c600294cac004bcc80459735f92c553
ARWR,2025-09-03T13:15:21+00:00,Arrowhead: Upcoming Plozasiran PDUFA Review Date And Subsequent Expansion In Place,SeekingAlpha,https://finnhub.io/api/news?id=e36527748226a834b22caaae0ea865596c2d61d0d0553ddbd84c9a2055e4a346
ARWR,2025-09-02T21:05:50+00:00,Arrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 Billion,Yahoo,https://finnhub.io/api/news?id=a1cd508b1acf6d18a49350edd743bcde359cc1fa554d886c828b8e0f2ca08952
ARWR,2025-09-02T15:23:00+00:00,ARWR: Signs Collaboration Agreement with Novartis with $200 Million Upfront…,Yahoo,https://finnhub.io/api/news?id=8f260188d4925bc8912216395728633c23052f4d7f23b2308c4974a6aa1d894c
ARWR,2025-09-02T13:03:00+00:00,Novartis thinks Arrowhead brain drug can succeed where others couldn’t,Yahoo,https://finnhub.io/api/news?id=1894fd29362bdb9bb8f729147ebf5fd2be9ccd7d0c33c65f6d1d6d7282ff2e76
ARWR,2025-09-02T12:30:00+00:00,Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement,Yahoo,https://finnhub.io/api/news?id=3728afe6638db2e2b5790895d266fc026b089e5009fc9d204c6bf51c9a661930
ARWR,2025-09-01T11:19:03+00:00,"Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past year",Yahoo,https://finnhub.io/api/news?id=ad41e3a6be31551da1fe36df9c9eaa54bab68f80f29653b382cd375aaf5d924f
ARWR,2025-08-27T11:30:00+00:00,Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences,Yahoo,https://finnhub.io/api/news?id=a05fcc798df76a911142c3d41a62e25872eacbe7d866fb5095f540b45f5fee6e
ARWR,2025-08-21T13:33:24+00:00,Sarepta Gets Breathing Room in $700 Million Debt Restructure,Yahoo,https://finnhub.io/api/news?id=fd82f246356fdf65ece1d8e5417b1a1c40424fea4c2e9ca989fc5d86701b2826
ARWR,2025-08-20T20:41:43+00:00,"Goodbye, Mag 7! These 3 Buy-Rated Small-Cap Stocks Are Starting to Outperform.",Yahoo,https://finnhub.io/api/news?id=36863ffd2a65b449055c26efc48810ec149519c80e806061cff7a3bd5c462d39
ARWR,2025-08-18T16:31:54+00:00,Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue,Yahoo,https://finnhub.io/api/news?id=3abd67fe1883aa09bed507f6079aed335d98fb27c1af9f04ddb080d1025c3a78
ARWR,2025-08-14T15:41:00+00:00,Sarepta Sells Biotech Stake to Raise Cash as Elevidys Troubles Hit Home,Yahoo,https://finnhub.io/api/news?id=eb7c765cad508b8422576a3967daf8ed25a0a4844fdf181be7f8fdc5e13b074e
ARWR,2025-08-14T15:24:00+00:00,Sarepta Sells Arrowhead Stake to Fund Milestone Payment,Yahoo,https://finnhub.io/api/news?id=e4a4f871bdd37dce2dbbb6190e9e847a7f728162b3e723e6517987a1dd7006a4
ARWR,2025-08-14T13:30:24+00:00,Sarepta Sells Arrowhead Stake To Stretch Its Cash Runway; And One Stock Dives,Yahoo,https://finnhub.io/api/news?id=fe69ce624d5e893b97d951b0bbd6a09a568a1af05eebd0efb3fb5c179cb6deb5
ARWR,2025-08-14T12:22:50+00:00,"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Inflation Data",Yahoo,https://finnhub.io/api/news?id=d6e10995a1b94ddaebf49b6190d9a212013d38131276fd3e19e063fd2383375f
ARWR,2025-08-14T11:29:00+00:00,"Sarepta sells Arrowhead shares as partnership, debt payments loom",Yahoo,https://finnhub.io/api/news?id=549dd7d11b3c8dbb0bace10a36a5a2056ab7626d8c2343fbdcbd333f86e822a0
ARWR,2025-08-13T20:12:00+00:00,Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment,Yahoo,https://finnhub.io/api/news?id=dff9b33e6a572d4761a40938e9b9eafde7c1b3f86b2f3c5269bc3e685369477d
ARWR,2025-08-13T20:10:00+00:00,Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics,Yahoo,https://finnhub.io/api/news?id=de2ab840e51b5629d6608b8c55c643292dfd410b6e1fe2ad71f75fa4dfcb7526
ARWR,2025-08-08T20:48:47+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=98c52fc028110a34cb683900a01d31bcdb0129efe738055bef7996e90a23d8a7
ARWR,2025-08-08T12:30:00+00:00,"ARWR: Countdown to Nov. 18, 2025 PDUFA for Plozasiran for FCS…",Yahoo,https://finnhub.io/api/news?id=19290f578935b897db4fa0378f3c1f581ab7217eab50d68e37b473ad00ecefd6
ARWR,2025-08-07T20:10:50+00:00,Arrowhead Research: Fiscal Q3 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=ffd320bb4824742bc889f88c119453a620ea37a04d27d36321c008ea8ca51271
ARWR,2025-08-07T20:01:00+00:00,Arrowhead Pharmaceuticals Reports Fiscal 2025 Third Quarter Results,Yahoo,https://finnhub.io/api/news?id=ccac7ef423ff9d1c8462df6fdd62cb1d415c5c27d5b04ac75e1f6934fe78f37a
ARWR,2025-08-04T15:07:00+00:00,Sarepta to Report Q2 Earnings: What's in Store for the Stock?,Yahoo,https://finnhub.io/api/news?id=2a9e0aba27c5099f9367b79aabf47cb1664fa5b6ceb968b3f8783f16068e296c
ARWR,2025-08-01T10:30:00+00:00,Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Candidate Plozasiran in Greater China to Sanofi,Yahoo,https://finnhub.io/api/news?id=ea57c82c7c87c4e163888bf7298c0c2c6f5102475749560dfa9151ba46c42cdb
ARWR,2025-07-31T15:58:28+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal",Yahoo,https://finnhub.io/api/news?id=c2d6fa58df6c137f68b2e5e70f820b63d6b039d945acae1dd47ac5f8887cc22b
ARWR,2025-07-30T12:30:00+00:00,Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval,Yahoo,https://finnhub.io/api/news?id=cc6e88c59d96802e89d8373a5ee1a7b7ff33163c7132d55ceec650591279265a
ARWR,2025-07-28T18:31:10+00:00,Dollar Climbs Most Since May as Trade Jitters Ease: Markets Wrap,Yahoo,https://finnhub.io/api/news?id=d88e6691539bd9dff68b90b2c67e6bf78298091f42c1289926ba4b92ed6d283d
ARWR,2025-07-28T17:13:55+00:00,"Sarepta Therapeutics Could Face Financial Trouble by 2027 if Elevidys Does Not Return to Market by Early 2026, RBC Says",Yahoo,https://finnhub.io/api/news?id=c10d9b5a1879e4332c7e6ca6e048d2c70a664798cfea2a246c09d507e069e46b
ARWR,2025-07-28T11:30:00+00:00,Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics,Yahoo,https://finnhub.io/api/news?id=cdd98685ddc7a5e8a5038a22571be5ab14ce4f50aa56757ac03507b8d6d1daee
ARWR,2025-07-23T13:28:24+00:00,Arrowhead Says Sarepta Expected to Meet Financial Obligations Despite Setbacks,Yahoo,https://finnhub.io/api/news?id=57851d9feaa2c705a0eec4e511c81b721ebba17f69468e2bd044fa823eacdf16
ARWR,2025-07-23T12:00:00+00:00,Arrowhead Pharmaceuticals Issues Statement on the Status of its Ongoing Agreement with Sarepta Therapeutics,Yahoo,https://finnhub.io/api/news?id=c2fc83132af74a49c54e7042a9d3abbf87402529c94c4df108fa4591f6b7d7e0
ARWR,2025-07-22T19:40:33+00:00,Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns,Yahoo,https://finnhub.io/api/news?id=2003a6a0d19bbc237853dd8eb0ad8d7d5c9bddc2353ab413b648e89b9b7c6436
ARWR,2025-07-22T13:30:54+00:00,How The Negative Developments At Sarepta Therapeutics Impact Arrowhead Pharmaceuticals,SeekingAlpha,https://finnhub.io/api/news?id=cda39deba289977364c9444ae3dd348c6792bfdffe82ac2f46786d33fee9b063
ARWR,2025-07-21T20:01:00+00:00,Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Third Quarter Results,Yahoo,https://finnhub.io/api/news?id=abf341da67f2efb38bff102a17a0d23bc61505a5762e3f96cde8f78f9f6dc88d
ARWR,2025-07-16T20:01:00+00:00,"Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label",Yahoo,https://finnhub.io/api/news?id=326215145a62e34e0e32082661c004b96628d3ed9450754967fe2d698979c8fa
ARWR,2025-07-09T09:32:42+00:00,Arrowhead doses first patient in Phase III trial of zodasiran for HoFH treatment,Yahoo,https://finnhub.io/api/news?id=b1689c78e426c1f911c2d75ce9e1bd83b3051d69125efa53518ff5dde15040a3
ARWR,2025-07-08T11:30:00+00:00,Arrowhead Pharmaceuticals Initiates Phase 3 YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia,Yahoo,https://finnhub.io/api/news?id=61f58c75a7b2bb860b260abc9face70b5a1051a7d141de821bbc719cf38bcde3
ARWR,2025-07-08T07:42:23+00:00,Arrowhead Pharmaceuticals initiates phase 3 Yosemite study of investigational zodasiran,Finnhub,https://finnhub.io/api/news?id=8341372b347b69b8e12b6874659a02e7b5f0c308c9c276bf7b2a198ccb931a0a
ARWR,2025-07-01T09:32:00+00:00,"Chronic Hepatitis B Market Analysis and Forecast, 2025-2035 | Diagnostic Advances, Innovative Therapies, and Rising Awareness Bolster Growth",Yahoo,https://finnhub.io/api/news?id=44f7d1b86cde4a4ba18875cf8e0b954e6f50a2c07b74ae708e9d3f961296dbdb
ARWR,2025-06-23T11:30:00+00:00,"Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran",Yahoo,https://finnhub.io/api/news?id=c038730c28ead0aec398572452e31f155076f81d8669e29d91fc0776fad79250
ARWR,2025-06-09T16:50:40+00:00,"Transcript : Arrowhead Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 02",Finnhub,https://finnhub.io/api/news?id=b6ef7fadc8d3963e20ca5884c9a7adb0939a70539e4c297517377391f79e772b
ARWR,2025-06-06T09:57:16+00:00,Arrowhead Pharmaceuticals : ERA 2025 ARO C3,Finnhub,https://finnhub.io/api/news?id=0bf714316e4aabdccf700770860969a0f2de5242522e5915d91399a45f82cb03
ARWR,2025-06-05T09:10:53+00:00,Jim Cramer on Arrowhead Pharmaceuticals (ARWR): “It Doesn’t Make Any Money”,Yahoo,https://finnhub.io/api/news?id=99445085da0bb14f38bbd111dc2d7856acff388530c05e9860597a8313db7bed
ARWR,2025-06-03T09:37:39+00:00,Arrowhead commences dosing in Phase I/IIa obesity treatment trial,Yahoo,https://finnhub.io/api/news?id=e04627aec3c377d192b91e2b42755d320aefd37363a08ce3a75f5bacf2941eb8
ARWR,2025-06-02T11:30:00+00:00,Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity,Yahoo,https://finnhub.io/api/news?id=572a1142fab2bf8acecad572224cddc60bfac322e3f4289a7740bf877f4e8b3c
ARWR,2025-05-30T11:35:00+00:00,abrdn Healthcare Opportunities Fund Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=b711ffff6bce49ff9d5022585a2f181130d7472e23b9296d94389bf9ea6cd4ef
ARWR,2025-05-30T00:52:06+00:00,Arrowhead Pharmaceuticals : NLA 2025 SHASTA 5 AP Study Design,Finnhub,https://finnhub.io/api/news?id=331447934d2280a4ba62f9c167418b7d337cdf57538287be83ecbf40760a495f
ARWR,2025-05-30T00:52:05+00:00,Arrowhead Pharmaceuticals : NLA 2025 PALISADE AP QOL FCS,Finnhub,https://finnhub.io/api/news?id=995d87aaf7f02e4a1d4e6d19a6f29b512040c36577a62d0ed5a3d3fd9b875418
ARWR,2025-05-29T17:45:27+00:00,Arrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade),SeekingAlpha,https://finnhub.io/api/news?id=d1e69a829de37d455cf25802b553b122b099cc1396b82b4792f06bd55d6cd4d6
ARWR,2025-05-29T11:30:00+00:00,Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences,Yahoo,https://finnhub.io/api/news?id=aceddfb2edda08f572299dafd8441345b9c7686ba5434971a19e55e80a238609
ARWR,2025-05-29T07:40:11+00:00,Arrowhead Pharmaceuticals : NLA 2025 ARO DIMER PA,Finnhub,https://finnhub.io/api/news?id=2cb884c58e83040e49de520f49d0a0e0a21dd88b3aa503f6d82214bb2a7c60da
ARWR,2025-05-22T07:36:05+00:00,Arrowhead Pharmaceuticals : TIDES USA 2025 CNS,Finnhub,https://finnhub.io/api/news?id=e7d72c43bc2a57e9471195581d0717f275209479ad1ef59254fa8150a3abf8d8
ARWR,2025-05-18T20:06:54+00:00,Arrowhead Pharmaceuticals : ATS 2025 RAGE Preclinical 1,Finnhub,https://finnhub.io/api/news?id=95c3e6cea3e9faf91f188578790bd0925b04d4bd1174af853682fafefc7eb3a2
ARWR,2025-05-18T20:06:54+00:00,Arrowhead Pharmaceuticals : ATS 2025 RAGE Preclinical 2,Finnhub,https://finnhub.io/api/news?id=57aa4727942f75728fce67b368b89f009e0270ef15a17625ca97ed818f1c19ae
ARWR,2025-05-15T10:10:00+00:00,ARWR: Multiple Value Drivers for Long-Term Growth…,Yahoo,https://finnhub.io/api/news?id=bfad3752857751ad551b01d0060493969c712783443f0608950f58a63d15d23e
ARWR,2025-05-13T07:07:52+00:00,Arrowhead Pharmaceuticals Inc (ARWR) Q2 2025 Earnings Call Highlights: Strong Financials and ...,Yahoo,https://finnhub.io/api/news?id=e09fb6ec88f0a061d372829a3594a948eba215110a1ec2e8166cf235ae65d449
ARWR,2025-05-12T21:56:40+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=4ff70f0f0da3e55feca8e1acd2165f8dee965b1b108e0054f47d6f22219aab19
ARWR,2025-05-12T20:10:47+00:00,Arrowhead Research: Fiscal Q2 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=41cca3e066bffecfa21aae89fd420827a31d6a93567fec1c72dc79c7d3d66eac
ARWR,2025-05-12T20:01:00+00:00,Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results,Yahoo,https://finnhub.io/api/news?id=4f3edb5380a130049651002e3da8457c2d7f90ea37aac9ff53cfba0dba643b54
ARWR,2025-05-12T17:08:08+00:00,Arrowhead Pharmaceuticals : ARWR FQ2 2025 Script FINAL,Finnhub,https://finnhub.io/api/news?id=9d0bd93003e90e22724fca749e099bc5f593bfcaef9a7257bc5d28f17be2ded1
ARWR,2025-05-12T16:03:11+00:00,Arrowhead Pharmaceuticals : ECO2025 ALK7,Finnhub,https://finnhub.io/api/news?id=dbce2395eec0a221fcffc767aea062c8ee4e36432c3ff328f8abfac9f86d8bba
ARWR,2025-05-12T16:01:00+00:00,"Transcript : Arrowhead Pharmaceuticals, Inc., Q2 2025 Earnings Call, May 12, 2025",Finnhub,https://finnhub.io/api/news?id=dcf55046cc557e449037f6be5797fd08483ed2c440a998a73b33ac5e44a29f0b
ARWR,2025-05-07T14:14:41+00:00,Sarepta: ELEVIDYS DMD Treatment Setback Brings Downgrade To Hold Rating,SeekingAlpha,https://finnhub.io/api/news?id=e6035971b93436013b1c69e8a22fe262d432b2750a13f6ee2fbab632f2ba546a
ARWR,2025-05-07T12:31:00+00:00,"SRPT Q1 Earnings Miss, Sales Beat, Stock Slides 21% on '25 View Cut",Yahoo,https://finnhub.io/api/news?id=1cc20f8697731ce6824e7445ef893adc8891028516e92b4e0a6cbb2b80bc012d
ARWR,2025-05-07T12:14:34+00:00,Sarepta Therapeutics: Lowered Elevidys Guidance Warrant Ratings Downgrade,SeekingAlpha,https://finnhub.io/api/news?id=352abb3cca9be0f5bb9bc63445fc2b55a992e3f5a8176bdb1e83357e5f0a649a
ARWR,2025-05-07T11:30:00+00:00,Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences,Yahoo,https://finnhub.io/api/news?id=5d6f93a0765d92f165493b3a2af61a47d0fa7bcb6738bcf7995c3535d2b3d2e3
ARWR,2025-05-07T07:30:00+00:00,"Transcript : Arrowhead Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 11",Finnhub,https://finnhub.io/api/news?id=53feed8f80e1c85bf5b5902f4c571536399aff0e5aeec2ad33baf100b955e92e
ARWR,2025-05-07T06:17:22+00:00,Arrowhead Pharmaceuticals : EAS 2025 GATEWAY,Finnhub,https://finnhub.io/api/news?id=63457db2b1f6d950c7f3e51d1ba9be535f609d0b778b4f12064f60f3edb1234c
ARWR,2025-05-05T11:49:37+00:00,"Why Arrowhead Pharmaceuticals, Inc. (ARWR) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential",Yahoo,https://finnhub.io/api/news?id=ac216832386ccce4a8680181838b3af4addc92460c41512c68ea07615f49f385
ARWR,2025-04-30T20:01:00+00:00,Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Second Quarter Results,Yahoo,https://finnhub.io/api/news?id=f6dbca15ac9525503906933109d09681de217253760c7b1b3c3b797af5196521
ARWR,2025-04-26T08:50:33+00:00,Novo Nordisk: Examining Tariff And Pricing Risks,SeekingAlpha,https://finnhub.io/api/news?id=4959a9af926c223a27f36e094f6b83b35e55adb6ab39736fc8461b7df81548ce
ARWR,2025-04-19T05:30:00+00:00,ClearBridge Small Cap Strategy Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=554fb28300d5cbf7cd62071c4d996ace1caf19bbbfc2608e17958a084aa7627d
ARWR,2025-04-15T20:00:00+00:00,Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer,Yahoo,https://finnhub.io/api/news?id=1238a6cef0d6b5c70a0c8658e3fe8191730ce3b96204977ed237720a52603e3e
ARWR,2025-04-15T11:23:06+00:00,Arrowhead Pharmaceuticals : Corporate Presentation Short April 2025 Final,Finnhub,https://finnhub.io/api/news?id=68af8ea2826c28b6502b568747ba5dbbb01abf04b72031731b79c9acb00cb087
ARWR,2025-04-07T07:03:15+00:00,Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(4),Finnhub,https://finnhub.io/api/news?id=8c19d595067b0aa7a85a1e23293c31ac6cb5fad7a12ca5bb678f6eb539ce91d9
ARWR,2025-03-28T09:00:39+00:00,RNA Biotechs: Current State And Outlook,SeekingAlpha,https://finnhub.io/api/news?id=1f3638fe5d94396e4de4d10d757d411c0123cc3cebc9f3478bbed086637c300b
ARWR,2025-03-25T10:02:29+00:00,"Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is favoured by institutional owners who hold 70% of the company",Yahoo,https://finnhub.io/api/news?id=3656770b0f823f9a62667221196eaedd8f2a80984c469b679cea857bdd9d1c58
ARWR,2025-03-21T17:56:13+00:00,Arrowhead Pharmaceuticals Is Finally Arriving,SeekingAlpha,https://finnhub.io/api/news?id=fe653db4395d074d87c0423f17a0ddc36e08791e399f05c6eaa22357a616d564
ARWR,2025-03-10T18:02:01+00:00,Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases,Yahoo,https://finnhub.io/api/news?id=d2efc97789ab94d29311eb0c78362e6497c1f13dca242623738f7f20ac4f4c7e
ARWR,2025-03-10T11:30:00+00:00,Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy,Yahoo,https://finnhub.io/api/news?id=5e57577c83e01bea09dd0f1aac8ae07fcb043ce12ecd8d8cbdd54bf853e98453
ARWR,2025-03-06T13:45:00+00:00,Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases,Yahoo,https://finnhub.io/api/news?id=e3ec2bac7afe9f3abcf46d0d4f9a10d29d50ac6119ee0a7ad56a8e4847be73b6
ARWR,2025-03-06T11:28:06+00:00,Arrowhead Pharmaceuticals : RNA Leaders Europe 2025 Obesity View Presentation,Finnhub,https://finnhub.io/api/news?id=939c2ed95573a766e16d27872ef4f5e84b1f7735b64eeb96a79fb9f183f57c5a
ARWR,2025-03-04T08:15:00+00:00,Sarepta Therapeutics' Long-Term Potential Intact Despite Near-Term Stock Weakness,SeekingAlpha,https://finnhub.io/api/news?id=b59f1ad06d3f1aaca7a8260d946eb58cc6e147ee80952e738e67d3f2dedbd2d7
ARWR,2025-02-28T14:00:00+00:00,Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS),Yahoo,https://finnhub.io/api/news?id=0e3e54012f7a54b17640a22c186c640ae2c79243e0616b14029c39a2cc80c1c3
ARWR,2025-02-25T12:30:00+00:00,Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity,Yahoo,https://finnhub.io/api/news?id=f8000a8051aebce72600d4568cdc2ab76b50fd04b10d38a8a4660ca98ba77744
ARWR,2025-02-20T17:15:50+00:00,Arrowhead Pharmaceuticals (ARWR): Among the Most Oversold Healthcare Stocks to Buy Now,Yahoo,https://finnhub.io/api/news?id=c017a0f6aa1c341fe45726574bd470e82340d40ee7f3a8c5f84675d6674e6f28
ARWR,2025-02-19T11:53:04+00:00,Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions,SeekingAlpha,https://finnhub.io/api/news?id=194d450c55a9729c6dacfb01085284f3615f9e97bbec0c3ee34d4d8520e403c0
ARWR,2025-02-12T14:22:00+00:00,ARWR: Multiple Catalysts Ahead in 2025…,Yahoo,https://finnhub.io/api/news?id=39ff3530bbb76852a4f4f92753ee094288103ee9278c84a760a362300af7fcdf
ARWR,2025-02-12T10:58:19+00:00,Arrowhead Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations,Yahoo,https://finnhub.io/api/news?id=436342c66675969840e206577efcbbb248ba716930ccbf9d14b22d3dadf5ef6a
ARWR,2025-02-11T15:10:02+00:00,Q1 2025 Arrowhead Pharmaceuticals Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=16d96b11a05248f35707238368d0bdb754e9295159deaff3f84c208e99a02a51
ARWR,2025-02-11T07:06:47+00:00,Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ...,Yahoo,https://finnhub.io/api/news?id=9d15c74d32686c18b8e97deaaede54a3606c3f8bbe3ae9bee6dad780e3e5ee18
ARWR,2025-02-10T21:35:25+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=ffb2c7ac289720c81694e0db76a099e23be8db50006f937947f7c2e51952cafd
ARWR,2025-02-10T21:08:08+00:00,Arrowhead Research: Fiscal Q1 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=c7061031994783f9a5d85e14ed8a2f45fb603c301bd76b3d13aca3dd37c4441f
ARWR,2025-02-10T21:01:00+00:00,Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results,Yahoo,https://finnhub.io/api/news?id=2689d590f05a0309c977eac0b9b3127e54c173d2d4656947244b1e70dde21cbd
ARWR,2025-02-10T13:30:00+00:00,Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics,Yahoo,https://finnhub.io/api/news?id=e28c152faebd882bb06abe974b8c2648bf8f75eb52e7bd263de8d29ff85bd25c
ARWR,2025-02-10T04:22:47+00:00,Cautious On Arrowhead Pharmaceuticals' FDA NDA Acceptance Due To Valuation Concerns,SeekingAlpha,https://finnhub.io/api/news?id=c0e0ecb614e76b2df98ece704c0f97ce2b3cf6581e379151c4c6916306e2957d
ARWR,2025-01-26T18:00:00+00:00,"Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) added to S&P 600 Health Care",Finnhub,https://finnhub.io/api/news?id=abe9653988a71d791869bcda227ea27f7ec840bcdc167bab5a45c401ec702710
ARWR,2025-01-26T18:00:00+00:00,"Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) dropped from S&P 400",Finnhub,https://finnhub.io/api/news?id=1dc1cd69d58d9ebfd72bd1b885d395c521c68b2b04cab9958ac2df8fe5855ddf
ARWR,2025-01-26T18:00:00+00:00,"Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) dropped from S&P 400 Health Care",Finnhub,https://finnhub.io/api/news?id=6a0296a01b121cb76f8436d17a435bac89579a922f87296f2215fb850357b64d
ARWR,2025-01-26T18:00:00+00:00,"Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) dropped from S&P 400 - Biotechnology",Finnhub,https://finnhub.io/api/news?id=7cf8d763f591febd1a4323afa0e7d274646c9ebb07bc76921fbd69e1d9413ec7
ARWR,2025-01-26T18:00:00+00:00,"Arrowhead Pharmaceuticals, Inc.(NasdaqGS: ARWR) added to S&P 600",Finnhub,https://finnhub.io/api/news?id=df6f002c5f144a8879d35f0f9a63cde78f40e4a8bf8f142881413258286d3917
ARWR,2025-01-22T22:54:00+00:00,Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600,Yahoo,https://finnhub.io/api/news?id=5577369a948050223287db9028ea659cfa2f7e32667112278bb9637493605b4a
ARWR,2025-01-22T21:00:00+00:00,Arrowhead Pharmaceuticals to Webcast Fiscal 2025 First Quarter Results,Yahoo,https://finnhub.io/api/news?id=c2bb7cae0bb95c6516eefa191f4cb82cac803ac159f584e2d44ba655116a7477
ARWR,2025-01-20T10:28:25+00:00,Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome,Finnhub,https://finnhub.io/api/news?id=cf178e240dc384d5c62410be97325fdafe4f419beceb15d893ebbf14374ab493
ARWR,2025-01-17T17:14:10+00:00,FDA Accepts Arrowhead Pharmaceuticals' Drug Application for Genetic Disease Treatment,Finnhub,https://finnhub.io/api/news?id=1ec146f6466b4ac44f02ce28a2c27a61e48ab8facf3e0d703272d2736f969705
ARWR,2024-12-24T13:20:03+00:00,Arrowhead doses first patient in Phase I/IIa RNA obesity therapy trial,Yahoo,https://finnhub.io/api/news?id=f7945367b3b465045006e2095983af475caa9ab789227dc7a967402892c5c124
ARWR,2024-12-23T12:30:00+00:00,Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity,Yahoo,https://finnhub.io/api/news?id=73d9170c17412d9410a22bcef20d7187903f360d8d6a81c9bc453690a3908d96
ARWR,2024-12-18T06:03:10+00:00,Arrowhead Pharmaceuticals : Management Change/Compensation Form 8 K,Finnhub,https://finnhub.io/api/news?id=83dfb100411193401e95ed7ba46a70691daee2bae6bc3ba55c76f48addad5578
ARWR,2024-12-13T10:37:07+00:00,"Arrowhead Pharmaceuticals : 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) WCIRDC 2024 OralWCIRDC 2024 Poster",Finnhub,https://finnhub.io/api/news?id=958477c58347ae481eabf0fa5def865e8f82cd769c82f06f4ee735e90b459c36
ARWR,2024-12-11T12:30:00+00:00,Arrowhead Pharmaceuticals Presents Interim Clinical Data on ARO-CFB for the Treatment of Complement Mediated Diseases,Yahoo,https://finnhub.io/api/news?id=7bb5239abbe8b08f153cae353b0e9f3efcc55c77f6a9d313cbe748e32ced0578
ARWR,2024-12-07T14:31:07+00:00,"Shareholders in Arrowhead Pharmaceuticals (NASDAQ:ARWR) have lost 66%, as stock drops 9.3% this past week",Yahoo,https://finnhub.io/api/news?id=2cf0ed6b5db9702cd3704ad662b725df43e9dc52236bed516f75c0d2d53b2670
ARWR,2024-12-04T12:40:21+00:00,Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment,Yahoo,https://finnhub.io/api/news?id=dc486106fa76777e3830682e854ea61d59dd3a5f09c8c0f271c5502157d846cb
ARWR,2024-12-03T12:30:00+00:00,Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity,Yahoo,https://finnhub.io/api/news?id=602e4b1436abdc6e31db0c7ec01d66d8c97391c8a9303eefc9ffbf3a4c9a4577
ARWR,2024-12-03T11:24:00+00:00,ARWR: License and Collaboration Deal with Sarepta Includes $825 Million Upon Closing…,Yahoo,https://finnhub.io/api/news?id=e563b67f540d6e1a0cd98c9c60883a2fb258a3bff99e33cd75b0e9858d183a3a
ARWR,2024-12-02T12:30:00+00:00,Arrowhead Pharmaceuticals to Participate in Upcoming December 2024 Conferences,Yahoo,https://finnhub.io/api/news?id=21f254451615b848ab1ebc3618d85995ea44d690743670652f74e047092318ce
ARWR,2024-11-30T11:00:08+00:00,Arrowhead price target lowered to $24 from $27 at Bernstein,Yahoo,https://finnhub.io/api/news?id=dc073fc417cb27c4003955a784633ee26e54653825586e5de4766095f9e12a57
ARWR,2024-11-29T06:00:19+00:00,Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy Reliance,Yahoo,https://finnhub.io/api/news?id=1f2f83f31c2e089d773a89a498d197b54e1e905f0fda7a15919e7aaed40f0277
ARWR,2024-11-28T13:15:10+00:00,Sarepta price target lowered to $202 from $205 at Needham,Yahoo,https://finnhub.io/api/news?id=54cbf8318cc1820676b0f63494308115edf3328bab0ebf764538a2bf080a16c4
ARWR,2024-11-27T17:40:24+00:00,Q4 2024 Arrowhead Pharmaceuticals Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=b87e3827b6c0aee7cd91d4099f748ed349e253b7d3f120ba0c916e159e31424a
ARWR,2024-11-27T16:31:00+00:00,SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies,Yahoo,https://finnhub.io/api/news?id=6b63336ed542d6c49fce02596490b7a58735b3202778c74db4efa8a0dbf08e26
ARWR,2024-11-27T16:07:12+00:00,Arrowhead Stock Rockets 16% After Major Licensing Deal,Yahoo,https://finnhub.io/api/news?id=c5570c7a8d7539a993f6cb1209b401454ef832d5de656cfa9cb4e1f2330883f1
ARWR,2024-11-27T15:02:57+00:00,Arrowhead: The Sarepta Partnership Validates RNAi Platform And Reduces Risk,SeekingAlpha,https://finnhub.io/api/news?id=57e95017748a8558ba136342faf60f13b76823b8983a5ae88a8b7d2429d02100
ARWR,2024-11-27T12:21:14+00:00,Sarepta to pay Arrowhead $500M + in licensing deal for siRNA-based treatments,Yahoo,https://finnhub.io/api/news?id=8e04e3882fe4c5a7480b4d6718e17584e31e0ebc165436108dbc78a9cabe8bb5
ARWR,2024-11-27T12:20:10+00:00,"Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta CEO to board",Yahoo,https://finnhub.io/api/news?id=eaf670124e171a340cb2d268c20ff1d267cafbfba54e574a03f81c6d04b36f27
ARWR,2024-11-27T09:33:21+00:00,Arrowhead and Sarepta link for rare genetic disease treatments,Yahoo,https://finnhub.io/api/news?id=98ce723c4d31add4e091c0de2a2749867206b7f192b66b30bc7f0251dd747a27
ARWR,2024-11-27T07:04:06+00:00,Arrowhead Pharmaceuticals Inc (ARWR) Q4 2024 Earnings Call Highlights: Transformational ...,Yahoo,https://finnhub.io/api/news?id=5e117373ec8225172cda92249001707aa79bbd4e6c11af1b3bf0af7c212e87fe
ARWR,2024-11-26T23:08:49+00:00,"Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2024 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=2a521946e623529de1aaba44a883c0b2d7163c2facff2fe6808d881cdedde5ba
ARWR,2024-11-26T21:05:55+00:00,"Arrowhead Pharma, Sarepta TX ink new gene therapy deal",Yahoo,https://finnhub.io/api/news?id=e03d9edcd3340792046003c6fc84c6248d502fab037e0b1098c497b7b4aa512e
ARWR,2024-11-26T21:00:00+00:00,Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results,Yahoo,https://finnhub.io/api/news?id=8ffc4ff7ee5654e327b8b377f2865f16848280d3a7bd8959e8d34e9a92cda3fb
ARWR,2024-11-26T18:02:23+00:00,Top Midday Gainers,Yahoo,https://finnhub.io/api/news?id=c045415d123ad2833c5505974536c592d05e23e9ebf5982b0a366e84969a1879
ARWR,2024-11-26T16:25:10+00:00,Arrowhead Pharmaceuticals : Reports 2024 Fiscal Year End Results Form 8 K,Finnhub,https://finnhub.io/api/news?id=0bad637f5bec400a649a9c837490233928436924f53e0840f753d273bac591ae
ARWR,2024-11-26T15:55:30+00:00,"Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal",Yahoo,https://finnhub.io/api/news?id=0197fdfde112c2a6f17521ad39fe632788e59c06f3855a14965ef130ff40e495
ARWR,2024-11-26T13:14:48+00:00,"Arrowhead Pharma, Sarepta Therapeutics Sign Licensing, Partnership Deal for Clinical, Preclinical Programs",Yahoo,https://finnhub.io/api/news?id=26be5b5e539b8658137caf884882b0791045443ae40c45ec715b492cc6d496b9
ARWR,2024-11-26T12:00:00+00:00,Arrowhead Pharmaceuticals Announces Global License and Collaboration Agreement with Sarepta Therapeutics for Multiple Clinical and Preclinical Programs,Yahoo,https://finnhub.io/api/news?id=666ab31ea7b8fa8e2891d446505b8c751be8724e588878f1e1be05be9f36b0a3
ARWR,2024-11-22T12:41:34+00:00,Arrowhead Pharmaceuticals Inc. (ARWR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts,Yahoo,https://finnhub.io/api/news?id=974ec1a74547273f61ef092cb1f25eb41867177da5e99c955220385a41823780
ARWR,2024-11-18T12:31:00+00:00,Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome,Yahoo,https://finnhub.io/api/news?id=bf9eb416c186ed1676e56dc09df50db578c9e0e18bbe5883d9729c3619e5c70c
ARWR,2024-11-18T12:30:00+00:00,Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran,Yahoo,https://finnhub.io/api/news?id=d7173ac0c696beccf793b088b2aa41beac747822707b5adc59a4f754d21c8068
